SCHEMBL11944854

SCHEMBL11944854

CS(=O)(=O)N1CCN(c2cnn(-c3cc(F)cc(F)c3)c(=O)c2OCC2CCCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ DCTPP1 Q9H773 1/20 0.44
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39
▸ NCOA1 Q15788 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ SLC2A1 P11166 1/20 0.35
▸ SLC2A3 P11169 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ SLC6A9 P48067 2/20 0.33
▸ NPY5R Q15761 1/20 0.33
▸ HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11944878 0.90 GPR119 (0.39) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11944829 0.90 POLB (0.37) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11944025 0.88 ALDH1A1 (0.41) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11944036 0.86 ALDH1A1 (0.48) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11944019 0.85 ALDH1A1 (0.48) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11945165 0.82 ALDH1A1 (0.45) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11945434 0.82 ALDH1A1 (0.45) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11944479 0.82 ALDH1A1 (0.43) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11945248 0.81 ALDH1A1 (0.50) ALDH1A1DCTPP1POLBCYP3A4CYP2C19
SCHEMBL11943771 0.81 ALDH1A1 (0.48) ALDH1A1DCTPP1POLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA ALDH1A1 2437/4885DCTPP1 625/4885POLB 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback